Join to View Full Profile
200 S Manchester AveSte 400Orange, CA 92868
Phone+1 714-456-7772
Dr. Warnecke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Brian Warnecke, DO, is an oncology specialist based in Orange, CA. He completed his fellowship in Hematology and Medical Oncology at the University of California, Irvine, from 2022 to 2025. Dr. Warnecke earned his medical degree from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 2019 and completed his residency in Internal Medicine at the University of Texas Health Science Center San Antonio from 2019 to 2022. His undergraduate studies in Psychobiology were completed at the University of California, Los Angeles, in 2013. Dr. Warnecke has published several articles, including research on Adagrasib in advanced NSCLC and case reports on goserelin-induced chemical burn, multiorgan failure from nivolumab and ipilimumab, and COVID-19-induced thrombotic microangiopathy.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2022 - 2025
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2019 - 2022
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2019
University of California, Los AngelesBS, Psychobiology, 2009 - 2013
Certifications & Licensure
CA State License 2022 - 2026
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA).Andrew Ta, Supreet Kaur, Michael Mader, Kathleen Franklin, Madison Williams
Leukemia & Lymphoma. 2024-08-01 - Adagrasib in the Treatment of KRAS p.G12C Positive Advanced NSCLC: Design, Development and Place in Therapy.Brian Warnecke, Misako Nagasaka
Drug Design, Development and Therapy. 2024-01-01 - Goserelin-Induced Chemical Burn: A Case Report and Review of the Literature.Aditya Mahadevan, Brian Warnecke, Elaine Chiao, Nellie Nafissi, Kritisha Parajuli
Cureus. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
